Cargando…
Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness
BACKGROUND: Motion sickness is characterized by nausea and vomiting among a constellation of symptoms. Symptom severity is dynamic and distressing. Most validated motion sickness scales are time-intensive and effortful, with alternative scales having uncertain performance or non-specific measures. A...
Autores principales: | Czeisler, Mark É., Pruski, Justina M., Wang, Pan, Wang, Jingyuan, Xiao, Changfu, Polymeropoulos, Mihael H., Polymeropoulos, Vasilios M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815635/ https://www.ncbi.nlm.nih.gov/pubmed/36602998 http://dx.doi.org/10.1371/journal.pone.0280058 |
Ejemplares similares
-
Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study
por: Polymeropoulos, Vasilios M., et al.
Publicado: (2020) -
Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial
por: Polymeropoulos, Christos M., et al.
Publicado: (2022) -
Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Polymeropoulos, Christos M., et al.
Publicado: (2020) -
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility
por: Smieszek, Sandra P., et al.
Publicado: (2021) -
Tasimelteon safely and effectively improves sleep in Smith–Magenis syndrome: a double-blind randomized trial followed by an open-label extension
por: Polymeropoulos, Christos M., et al.
Publicado: (2021)